Anders Nielsen

Head of Department/Head of Research

(+47) 913 50 435
anders.nielsen@nibio.no

Place
Ås O43

Visiting address
Oluf Thesens vei 43, 1433 Ås

Abstract

It is highly unlikely that Anagyrus vladimiri will be able to establish or spread in Norway. There are no native host organisms, and winter temperatures are too low. Therefore, it is likely that the parasitic wasp will not affect local biodiversity. Thus concludes the Norwegian Scientific Committee for Food and Environment (VKM). Background VKM has assessed the environmental risk of using the product Citripar in Norway. The risk assessment was carried out at the request of the Norwegian Food Safety Authority. Citripar, a product for biological control, is being sought for approval for use in Norway. The product contains the parasitic wasp Anagyrus vladimiri and is intended to be used against mealybugs, especially the species Planococcus citri and P. ficus, on fruits, berries, vegetables, and herbs in greenhouses and plastic tunnels, as well as on indoor plants. Conclusions There have been no reported observations of Anagyrus vladimiri in Norway. VKM assesses that Anagyrus vladimiri will not be able to establish and spread in Norway under current conditions. Anagyrus vladimiri will have no effect on biological diversity in Norway, as there are no known native host organisms that the wasp can parasitize. Individuals of what is now known as Anagyrus vladimiri were for many years identified as belonging to the species Anagyrus pseudococci. Anagyrus pseudococci and A. vladimiri belong to a complex of species that are almost impossible to distinguish from each other and are informally referred to as the Anagyrus pseudococci complex. The risk assessment is approved by VKM's Panel on Plant Health.

To document

Abstract

The Norwegian Environment Agency has asked VKM to evaluate the risks to biodiversity associated with the import of two species of leeches to Norway, Hirudo medicinalis and H. verbana (so-called medicinal leeches). In addition, they ask that the project group suggest mitigating measures that could reduce any potential risks, should import of the two species be granted.

To document

Abstract

The Norwegian Environment Agency has asked VKM to evaluate the risks to biodiversity associated with the import of two species of leeches to Norway, Hirudo medicinalis and H. verbana (so-called medicinal leeches). In addition, they ask that the project group suggest mitigating measures that could reduce any potential risks, should import of the two species be granted. Background Bloodsucking leeches have been employed by humans for millennia. The two species Hirudo medicinalis and H. verbana have dominated the trade in medicinal leeches in Europe. Overcollection combined with loss or degradation of freshwater habitats led to a precipitous decline in European populations by the 1800s and led to a corresponding increase in imports from Turkey, North Africa, Russia and the Middle East. By the turn of the 19th century, the demand for live leeches in Europe had tapered off as contemporary medicine developed, only to have a small resurgence over the last decades as live leeches became recognized as useful for a variety of medical and cosmetic procedures, and to be the source of bioactive molecules of interest to medical researchers. As traditional medicine in Asia also uses a variety of leech products, there is a robust global market for live leeches and leech derivatives that is being met mostly by leech aquaculture, where the live leech trade seems dominated by H. verbana. There is increasing interest in commercializing production and sale of three similar leech species, H. orientalis from Central Asia, H. sulukii from a small region in Turkey, and H. troctina from North Africa. Hirudo medicinalis has been used medicinally in Norway since at least the Middle Ages when they were used by barber-surgeons for bloodletting. Leeches have been dispensed by apothecaries up until the end of the 1950s. Phylogeographic studies have treated the species as native to southern Norway and the Norwegian Biodiversity Information Centre has numerous records of H. medicinalis, with recent records primarily from the eastern coast of southern Norway. The Norwegian Red List for Species categorizes H. medicinalis as being of Least Concern in Norway. Hirudo verbana naturally occurs in southern Europe and has not been observed in Scandinavia so far (see map in Figure 2). Methods for the risk assessment VKM established a small working group with expertise in invertebrates and risk assessment. Our group combed the scientific literature and relevant websites for information on the taxonomy, natural history, ecology, and medical uses of medicinal leeches broadly and H. medicinalis and H. verbana specifically. The project group contacted major leech providers in Europe and North America to learn more about leech production and sale. Using the EICAT (Environmental Impact Classification for Alien Taxa) system developed by the IUCN, The project group identified those mechanisms (“hazards”) through which these two species could affect native biodiversity in Norway should imported specimens become established in Norwegian nature, and characterized the risk related to each of these hazards. The project group then conducted a semi-quantitative risk assessment for the species according to four categories: Low, Medium, Possibly high, and High risk. Hazards: how likely, how impactful, and overall risks In our report, VKM regard H. medicinalis as a native species, since it is so treated by Hirudo experts and is widespread in Norway. The project group regards H. verbana as non-native to Norway. The potential hazards from the EICAT system that could be associated with introducing one or both species include predation and parasitism, competition, disease transmission, and hybridization. ................................ .................................... Conclusions VKM concludes that the overall risk to biodiversity in Norway from importing live H. medicinalis and H. verbana is low.